BioSpace News Archive

UF Health Rehabilitation Hospital, a collaboration between Select Medical and UF Health, has been recognized as the Best Physical Rehabilitation Center in Florida by Newsweek magazine, which partnered with global market research firm Statista Inc. in its first ranking of the country’s top facilities for rehabilitation care.

In non-dialysis and dialysis-dependent CKD patients, Major Adverse Cardiovascular Event (MACE) and MACE+ incidence rates were lowest when patients achieved hemoglobin levels ≥ 1 0 g/dL Two analyses o f pooled data from the roxadustat global Phase 3 development program t o be presented during the American Society of Nephrology Kidney Week 2020 Reimagined

Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, announced today the appointment of Amanda Hundt to the newly created position of Vice President of Corporate Communications.

Avioq, Inc. announces it has received approval from the U.S. Food and Drug Administration (FDA) for their Vio One™ HIV Profile™ Supplemental Assay. The HIV Profile™ assay is an enzyme-linked immunosorbent assay (ELISA) for confirmation and differentiation of individual antibodies directed to various gene products of HIV-1 (Group

Perrigo Company plc, a leading global provider of Quality, Affordable Self-Care Products, announced that its Board of Directors declared a quarterly dividend of $0.225 per share, payable on December 15, 2020 to shareholders of record on November 27, 2020.

Syngenta engaged university agricultural experts from across the U.S. to suggest solutions for the toughest weed management challenges farmers are facing

T-System, a CorroHealth company, is launching the App Showcase highlighting complementary solutions to their Emergency Department Information System (EDIS) platform.

Adaptive Phage Therapeutics Receives Orphan Drug Designation for PhageBank ™ in Prosthetic Joint Infections

Chinook Therapeutics, Inc. (NASDAQ: KDNY), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced three poster presentations and one oral presentation at ASN’s Kidney Week 2020 Reimagined.

Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company (the “Company”), announced today that its Special Meeting of Stockholders, scheduled for October 22, 2020, was convened and adjourned without any business being conducted due to the fact that a quorum was not achieved on the proposals to be approve